Published Abstracts
• Adachi J, Saag K, Delmas P, Liberman U, Emkey
R, Seeman E, Lane N, Kaufman J, Poubelle P, Hawkins F, Correa-Rotter
R, Menkes C, Rodriguez-Portales J, Schnitzer T, Block J,
Wing J, McIlwain H, Westhovens R, Brown J, Melo-Gomes J,
Gruber B, Yanover M, Leite M, Siminoski K, Nevitt
M Sharp J, Malice M, Dumortier T, Czachur M, Carofano W,
Daifotis D, Two-year effects of alendronate on bone mineral
density and vertebral fracture in patients on glucocorticoids:
a randomized, double-blind, placebo-controlled extension
trial, A, Arthritis Rheum, 2001;44:202-211
• Maksymowych W; Lambert R: LeClerq S; Wong
B; Aaron S; Russell A, Clinical and Radiological amelioration
of refractory peripheral Spondyloarthropathies by Pulse
Intravenous Pamidronate Therapy, Journal of Rheumatology
2001:28 (1):144-55
• Lien D, Jackson K, Monkhouse P, Halenar J,
Modry D, Siminoski K, Intervention prevents progression
of osteoporosis in patients awaiting lung transplantation,
J Heart Lung Transplant 2001; 20:225
• Siminoski K, Warshawski R, Jen H, Lee K, Accuracy
of physical examination for detection of thoracic vertebral
fractures", J Bone Miner Res 2001; 16(Suppl):S274
• Campbell N, O'Sullivan S, Siminoski K, Ponich
T, Steroid therapy and Crohns disease: an Ontario survey
of gastroenterologists' practice, Can J Gastro 2001;
15 (Suppl A): 48A
• O'Sullivan S, Campbell N, Siminoski K, Ponich
T, Gastroenterologists' role in osteoporosis associated
with steroid therapy for Crohns disease, Gastroenterol
2001; 120 (Suppl 1): A629
• Johnell O, Kanis J, Sarkar S, Wu, W, de Laet
C, Oden A, Pavo I, Relationships between age and prior
use of HRT on vertebral fracture risk reduction with raloxifene
in postmenopausal women: results from the MORE trial,
J Bone Miner Res 2001; 16 (Suppl):S414
• Ensrud KE, Cauley J, Zhou, L, Mason T,
Bowman, P, Harper K, Effect of raloxifene hydrochloride
(RLX) on bone mineral density (BMD) and bone turnover markers
in diabetic women: the multiple outcomes of raloxifene evaluation
(MORE) trial, J Bone Miner Res 2001; 16 (Suppl):S415
• Roux C, Pols H, Ringe J, Giraudeau B, Van De
langerijt L, Cahall, D, Delmas P, Women with silent osteoporosis:
IMPACT baseline data, J Bone Miner Res 2001; 16 (Suppl):S456
• Lindsay R, Scheele W, Clancy A, Mitlak H,
Incident vertebral fractures during and 18-month observation
interval following discontinuation of LY33334 [recombinant
human parathyroid hormone (1-34), rhPTH(1-34)] use in postmenopausal
women with osteoporosis, J Bone Miner Res 2001; 16 (Suppl):S162
• Chik C, Lee K, Warshawski R, Jen H, Siminoski
K, Impact of height loss due to vertebral fractures on
body mass index, Can Soc of Endocrin Metab and Can Diabetes
Ass Annual Meeting. Abstracts. 2001
• Modi S, Wood L, Siminoski K, Venner P, A
comparison of the prevalence of osteoporosis and vertebral
fractures in men with prostate cancer on various androgen
deprivation therapies: preliminary report, American
Society of Clinical Oncology Annual Meeting. In Press.
